2009
DOI: 10.1002/hed.21054
|View full text |Cite
|
Sign up to set email alerts
|

Novel treatment of first bite syndrome using botulinum toxin type A

Abstract: The BTA injection into affected parotid gland produces a decrease in the severity of first bite syndrome and improves the patient's quality of life.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
61
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 49 publications
(63 citation statements)
references
References 11 publications
1
61
0
1
Order By: Relevance
“…improving one's quality of life. 20 Such evidence makes BTA a promising treatment option for the patient presented in Case 2, and other patients experiencing similar post-surgical facial spasms.…”
Section: Auricular Dystoniamentioning
confidence: 94%
See 1 more Smart Citation
“…improving one's quality of life. 20 Such evidence makes BTA a promising treatment option for the patient presented in Case 2, and other patients experiencing similar post-surgical facial spasms.…”
Section: Auricular Dystoniamentioning
confidence: 94%
“…BTA works by blocking the transmission of parasympathetic impulses, specifically preventing the release of acetylcholine from the pre-synaptic neuron to various muscle and glandular tissues. 20 is translates into a reduction of pathological glandular secretion and movement. Due to its efficacy, minimally invasive nature, and the rarity of side effects, it has become a mainstay treatment for numerous disorders of the head and neck region.…”
mentioning
confidence: 99%
“…FBS is described as occurring following a surgical procedure in the paracervical region because of a lesion of the sympathetic nerve fibers innervating the parotid gland [6]. ES is described following SHL ossification.…”
Section: Commentsmentioning
confidence: 99%
“…Ali et al expected a recurrence of symptoms 4-6 months after the injection and scheduled the patient for a new BT injection. Lee et al divided BT injection into three doses of 11 IU of BT each, diluted in a physiological serum solution, for a total of 33 IU; they observed a significant difference in pain during eating and quality of life at 3 months in five patients [6]. Costaes-Marcos et al treated five patients with three concurrent injections of 10 IU of BT injected into the parotid gland.…”
Section: Commentsmentioning
confidence: 99%
See 1 more Smart Citation